Aclarion Inc (ACON)

NASDAQ
Currency in USD
7.1600
-0.1600(-2.19%)
Closed·
After Hours
7.1401-0.0199(-0.2779%)
·
ACON Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ACON is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.13007.5600
52 wk Range
6.20003,499.5105
Key Statistics
Edit
Prev. Close
7.16
Open
7.4995
Day's Range
7.13-7.56
52 wk Range
6.2-3,499.5105
Volume
15K
Average Volume (3m)
216.39K
1-Year Change
-99.72%
Book Value / Share
840.6
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACON Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11,758.4118
Upside
+164,123.63%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Aclarion Inc Company Profile

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and data transfer products, including AMBRA Healthcare, an imaging data transfer platform and NOCIWEB, a custom developed web-interface. In addition, it offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Compare ACON to Peers and Sector

Metrics to compare
ACON
Peers
Sector
Relationship
P/E Ratio
−0.6x−1.4x−0.5x
PEG Ratio
-−0.030.00
Price/Book
4.3x1.0x2.6x
Price / LTM Sales
91.2x1.7x2.9x
Upside (Analyst Target)
-22.4%51.4%
Fair Value Upside
Unlock15.1%9.5%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11,758.4118
(+164,123.63% Upside)

Earnings

Latest Release
Apr 09, 2025
EPS / Forecast
-- / -0.17
Revenue / Forecast
10.23K / --
EPS Revisions
Last 90 days

FAQ

What Is the Aclarion (ACON) Stock Price Today?

The Aclarion stock price today is 7.16

What Stock Exchange Does Aclarion Trade On?

Aclarion is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Aclarion?

The stock symbol for Aclarion is "ACON."

What Is the Aclarion Market Cap?

As of today, Aclarion market cap is 4.17M.

What Is Aclarion's Earnings Per Share (TTM)?

The Aclarion EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is ACON a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.